2716 Organometallics, Vol. 18, No. 14, 1999
Alaimo and Bergman
compound decomposes above 0 °C in about 1 min. Due to its
high thermal sensitivity, compound 6 was not characterized
further.
of CH2Cl2. Compound 9 was obtained as a red powder (401
mg, 0.512 mmol) in 91% yield. H NMR (CD2Cl2): δ 7.51 (br
1
m, 9H, aryl); 7.20 (br m, 6H, aryl); 1.66 (d, J ) 1.8 Hz, 15H,
C5(CH3)5); 0.92 (d, J ) 9.1 Hz, 6H, cis-Ir(CH3)2); 0.34 (s, 3H,
trans-IrCH3). 13C{1H} NMR (CD2Cl2): δ 134.2 (d, J ) 9.3 Hz,
aryl); 133.7 (br s, aryl); 132.0 (br s, aryl); 129.4 (d, J ) 10.6
Hz, aryl); 129.1 (d, J ) 10.5 Hz, aryl); 105.6 (d, J ) 2.8 Hz,
C5(CH3)5); 8.0 (s, C5(CH3)5); 7.6 (d, J ) 5.6 Hz, trans-IrCH3);
1.3 (d, J ) 10.7 Hz, cis-Ir(CH3)2). The 13C{1H} NMR resonance
of the triflate ligand was not observed. 19F{1H} NMR (CD2-
Cl2): δ -77.2 (s). 31P{1H} NMR (CD2Cl2): δ 5.46 (s). IR: 3410
(m), 2920 (m), 2335 (w), 1483 (m), 1436 (s), 1380 (m), 1292 (s),
1260 (s), 1165 (s), 1146 (s), 1093 (s), 1027 (s), 843 (w), 749 (s),
702 (s) cm-1. FABMS (m/z): 635.3 (M+ - OTf).
Gen er a l P r oced u r e for t h e Syn t h esis of Com p lexes
7-12. In the glovebox, a 50 mL Schlenk flask was charged
with 4, CH2Cl2, and a Teflon stirbar. The flask was fitted with
a septum, attached to a vacuum line, and cooled to -78 °C.
To the cold, stirred solution was added a CH2Cl2 solution of
CF3SO3H by gastight syringe over 1 min. The resulting bright
yellow solution of 6 was stirred at -78 °C for 5 min. Trialky-
lphosphine, -arsine, or -antimony was then added as a CH2-
Cl2 solution by gastight syringe over 1 min. The resulting
reaction mixture was allowed to stand in a -25 °C freezer
overnight. The volatile materials were then removed in vacuo
while the reaction mixture was maintained at -29 °C (dry ice/
o-xylene bath). The remaining residue was warmed to room
temperature, quickly brought into the glovebox, and rapidly
triturated at room temperature with pentane (5 × 2 mL) and
Et2O (5 × 2 mL). The remaining residue was dissolved in CH2-
Cl2 (5 mL) and the solution filtered through Celite. The volatile
materials were removed in vacuo to give compounds 7-12 as
powders that were stored as solids in the glovebox freezer at
-30 °C. Since air-sensitive complexes 7-12 are also relatively
thermally sensitive, they were handled at room temperature
only for brief periods of time. Combustion analyses were not
obtained for complexes 7-9 due to their high thermal sensitiv-
ity and their similarity to compounds 10-12. Although many
NMR spectra for complexes 7-12 were acquired at low
temperature, the short-term thermal stability of these com-
plexes allowed for rapid spectrum acquisition at ambient
temperature. The reported NMR data for 7-12 are for spectra
acquired at room temperature.
[Cp *(AsEt3)Ir Me3][OTf] (10). Compound 10 was synthe-
sized as described above using 99.6 mg (0.257 mmol) of 4 in
30 mL of CH2Cl2, 42.5 mg (0.283 mmol) of CF3SO3H in 10 mL
of CH2Cl2, and 208 mg (1.29 mmol) of triethylarsine in 10 mL
of CH2Cl2. Compound 10 was obtained as a red powder (144
1
mg, 0.211 mmol) in 82% yield. H NMR (CD2Cl2): δ 1.94 (q, J
) 7.8 Hz, 6H, As(CH2CH3)3); 1.56 (s, 15H, C5(CH3)5); 1.47 (t,
J ) 7.7 Hz, 9H, As(CH2CH3)3); 0.97 (s, 6H, cis-Ir(CH3)2); 0.56
(s, 3H, trans-IrCH3). 13C{1H} NMR (CD2Cl2): δ 103.3 (s, C5-
(CH3) ); 12.66 (s, As(CH2CH3)3); 9.6 (s, As(CH2CH3)3); 7.6 (s,
5
C5(CH3)5); 1.8 (s, trans-IrCH3); -8.9 (s, cis-Ir(CH3)2). The 13C-
{1H} NMR resonance of the triflate ligand was not observed.
19F{1H} NMR (CD2Cl2): δ -77.3. IR: 2978 (s), 2934 (s), 2924
(s), 2878 (s), 2850 (m), 2292 (w), 1730 (w), 1632 (w), 1460 (m),
1383 (m), 1271 (s), 1223 (s), 1142 (s), 1072 (w), 1030 (s), 837
(w), 803 (w), 749 (m), 708 (m), 636 (s), 570 (m), 552 (w), 515
(m) cm-1. FABMS (m/z): 535 (M+ - OTf). Anal. Calcd for
C
20H39AsF3IrO3S: C, 35.13; H, 5.75. Found: C, 34.87; H, 5.90.
[Cp *(P Me3)Ir Me3][OTf] (7). Compound 7 was synthesized
as described above using 19.1 mg (0.049 mmol) of 4 in 25 mL
of CH2Cl2, 8.1 mg (0.054 mmol) of CF3SO3H in 5 mL of CH2-
Cl2, and 4.9 mg (0.064 mmol) of trimethylphosphine in 10 mL
of CH2Cl2. Compound 7 was obtained as a colorless powder
[Cp *(AsP h 3)Ir Me3][OTf] (11). Compound 11 was synthe-
sized as described above using 73.1 mg (0.189 mmol) of 4 in
30 mL of CH2Cl2, 31.2 mg (0.208 mmol) of CF3SO3H in 10 mL
of CH2Cl2, and 289 mg (0.944 mmol) of triphenylarsine in 10
mL of CH2Cl2. Compound 11 was obtained as a red powder
1
(25 mg, 0.043 mmol) in 87% yield. H NMR (CD2Cl2): δ 1.60
1
(152 mg, 0.183 mmol) in 97% yield. H NMR (CD2Cl2): δ 7.51
(d, J ) 1.4 Hz, 15H, C5(CH3)5); 1.51 (d, J ) 10.3 Hz, 9H,
P(CH3)3); 0.92 (d, J ) 8.7 Hz, 6H, cis-Ir(CH3)2); 0.48 (s, 3H,
trans-IrCH3). 13C{1H} NMR (CD2Cl2): δ 104.1 (s, C5(CH3)5);
11.4 (d, J ) 44 Hz, P(CH3)3); 7.6 (s, C5(CH3)5); 3.3 (d, J ) 6
Hz, cis-Ir(CH3)2); 2.7 (d, J ) 13 Hz, trans-IrCH3). The 13C{1H}
NMR resonance of the triflate ligand was not observed. 19F-
{1H} NMR (CD2Cl2): δ -77.2 (s). 31P{1H} NMR (CD2Cl2): δ
-27.6 (s). IR: 2998 (s), 2983 (s), 2968 (s), 2938 (s), 2917 (s),
2907 (s), 2292 (w), 1493 (m), 1481 (m), 1460 (m), 1436 (m),
1420 (m), 1375 (m), 1317 (m), 1297 (s), 1262 (s), 1222 (s), 1146
(s), 1076 (w), 1030 (s), 953 (s), 887 (w), 843 (m), 751 (m), 733
(m), 678 (m), 637 (s), 571 (m), 516 (m) cm-1. FABMS (m/z):
calcd for C16H33IrP 449.1949 (M+ - OTf); found 449.1949.
[Cp *(P Et3)Ir Me3][OTf] (8). Compound 8 was synthesized
as described above using 101.3 mg (0.262 mmol) of 4 in 30
mL of CH2Cl2, 43.2 mg (0.288 mmol) of CF3SO3H in 10 mL of
CH2Cl2, and 155 mg (1.31 mmol) of triethylphosphine in 10
mL of CH2Cl2. Compound 8 was isolated as a colorless powder
(m, 9H, aryl); 7.25 (m, 6H, aryl); 1.62 (s, 15H, C5(CH3)5); 1.13
(s, 6H, cis-Ir(CH3)2); 0.65 (s, 3H, trans-IrCH3). 13C{1H} NMR
(CD2Cl2): δ 133.3 (s, aryl); 131.8 (s, aryl); 129.7 (s, aryl); 127.7
(s, aryl); 104.6 (s, C5(CH3) ); 7.7 (s, C5(CH3)5); 4.8 (s, trans-
5
IrCH3); -3.6 (s, cis-Ir(CH3)2). The 13C{1H} NMR resonance of
the triflate ligand was not observed. 19F{1H} NMR (CD2Cl2):
δ -77.0 (s). IR: 3053 (m), 2987 (s), 2922 (s), 2294 (w), 1977
(w), 1895 (w), 1824 (w), 1580 (m), 1481 (s), 1437 (s), 1380 (s),
1264 (br s), 1224 (s), 1186 (m), 1180 (s), 1075 (s), 1028 (s), 1000
(s), 841 (m), 803 (w), 740 (s), 696 (s), 635 (s), 571 (m), 516 (m),
479 (s) cm-1. Anal. Calcd for C32H39AsF3IrO3S: C, 46.37; H,
4.75. Found: C, 46.12; H, 4.79.
[Cp *(SbP h 3)Ir Me3][OTf] (12). Compound 12 was synthe-
sized as described above using 52.8 mg (0.136 mmol) of 4 in
10 mL of CH2Cl2, 22.5 mg (0.150 mmol) of CF3SO3H in 10 mL
of CH2Cl2, and 57.8 mg (0.164 mmol) of triphenylantimony in
5 mL of CH2Cl2. Compound 12 was obtained as a colorless
powder (108 mg, 0.124 mmol) in 91% yield. 1H NMR (CD2-
Cl2): δ 7.60 (m, 3H, aryl); 7.51 (m, 6H, aryl); 7.34 (m, 6H, aryl);
1.60 (s, 15H, C5(CH3)5); 1.17 (s, 6H, cis-Ir(CH3)2); 0.81 (s, 3H,
trans-IrCH3). 13C{1H} NMR (CD2Cl2): δ 135.9 (s, aryl); 132.1
(s, aryl); 130.5 (s, aryl); 124.2 (aryl); 104.1 (s, C5(CH3)5); 7.6
(s, C5(CH3)5); 2.2 (s, trans-IrCH3); -13.6 (s, cis-Ir(CH3)2). The
13C{1H} NMR resonance of the triflate ligand was not observed.
19F{1H} NMR (CD2Cl2): δ -77.3 (s). IR: 3065 (m), 2982 (s),
2916 (s), 2836 (m), 2294 (w), 1973 (w), 1892 (w), 1820 (w), 1725
(w), 1630 (w), 1576 (m), 1480 (s), 1453 (sh), 1433 (s), 1379 (m),
1333 (w), 1262 (s), 1222 (s), 1183 (m), 1148 (s), 1066 (m), 1030
(s), 997 (m), 919 (w), 843 (w), 800 (w), 737 (s), 696 (s), 637 (s),
571 (m), 517 (m), 460 (m) cm-1. FABMS (m/z): 725 (M+ - OTf).
Anal. Calcd for C32H39F3IrO3SSb: C, 43.94; H, 4.49. Found:
C, 44.14; H, 4.75.
1
(136 mg, 0.212 mmol) in 81% yield. H NMR (CD2Cl2): δ 1.88
(m, 6H, P(CH2CH3)3); 1.55 (d, J ) 1.8 Hz, 15H, C5(CH3)5); 1.07
(m, 9H, P(CH2CH3)3); 0.91 (d, J ) 10.8 Hz, 6H, cis-Ir(CH3)2);
0.52 (s, 3H, trans-IrCH3).13C{1H} NMR (CD2Cl2): δ 104.8 (d,
J ) 3.8 Hz, C5(CH3)5); 15.0 (d, J ) 36.3 Hz, P(CH2CH3)3); 9.8
(s, P(CH2CH3)3); 8.9 (d, J ) 4.5 Hz, trans-IrCH3); 7.9 (s, C5-
(CH3)5); -4.7 (d, J ) 11.6 Hz, cis-Ir(CH3)2). The 13C{1H} NMR
resonance of the triflate ligand was not observed. 19F{1H} NMR
(CD2Cl2): δ -77.4. 31P{1H} NMR (CD2Cl2): δ -13.0. Due to
the thermal sensitivity of this compound, 8 was not character-
ized further.
[Cp *(P P h 3)Ir Me3][OTf] (9). Compound 9 was synthesized
as described above using 218 mg (0.563 mmol) of 4 in 20 mL
of CH2Cl2, 88.7 mg (0.591 mmol) of CF3SO3H in 10 mL of CH2-
Cl2, and 155 mg (0.591 mmol) of triphenylphosphine in 10 mL